MedTrace Logo

SLE Vasculitis In Egyptian Patients

NCT04386889 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 20

Last updated 2020-12-14

No results posted yet for this study

Summary

Systemic lupus erythematosus (SLE) is a complex heterogeneous autoimmune disease with a wide variety of clinical and serological manifestations that may affect any organ. Vasculitis prevalence in SLE is reported to be between 11% and 36%.

Conditions

  • Vasculitis Lupus

Interventions

OTHER

Vasculitis In SLE

20 SLE female Egyptian patients, among them we are going to study the vasculitic pattern incidence.

Sponsors & Collaborators

  • Tabarak New Cairo Hospital (TNCH)

    lead OTHER

Study Design

Allocation
NA
Purpose
SCREENING
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
22 Years
Max Age
45 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2021-03-25
Primary Completion
2021-07-25
Completion
2021-08-25

Countries

  • Egypt

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04386889 on ClinicalTrials.gov